(R)-GNE-140 is a potent lactate dehydrogenase A (LDHA) inhibitor with IC50s of 3 nM and 5 nM for LDHA and LDHB respectively.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | Dehydrogenase ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trilostane | ✔ | 99+% | |||||||||||||||||
AGI-6780 |
+++
IDH2 R140Q mutant, IC50: 23 nM |
99%+ | |||||||||||||||||
Gimeracil | ✔ | 98% | |||||||||||||||||
AGI-5198 |
++
R132H-IDH1, IC50: 70 nM R132C-IDH1, IC50: 0.16 μM |
99%+ | |||||||||||||||||
SW033291 |
++++
15-PGDH, IC50: 1.5 nM 15-PGDH, Ki: 0.1 nM |
99%+ | |||||||||||||||||
Mycophenolic acid | ✔ | 99+% | |||||||||||||||||
Fomepizole | ✔ | 98% | |||||||||||||||||
Leflunomide | ✔ | 98% | |||||||||||||||||
3-Nitropropanoic acid | ✔ | 99%+ | |||||||||||||||||
Isovaleramide | ✔ | 98% | |||||||||||||||||
Mycophenolate Mofetil |
+++
Inosine monophosphate dehydrogenase I, IC50: 39 nM Inosine monophosphate dehydrogenase II, IC50: 27 nM |
98% | |||||||||||||||||
MK-8245 |
++++
SCD1 (rat), IC50: 3 nM SCD1 (mouse), IC50: 1 nM |
99%+ | |||||||||||||||||
Vidofludimus |
++
Human DHODH, IC50: 134 nM |
99%+ | |||||||||||||||||
Emodin | ✔ | 98% | |||||||||||||||||
Ivosidenib | ✔ | 98% | |||||||||||||||||
NCT-501 |
++
ALDH1A1, IC50: 40 nM |
98% | |||||||||||||||||
Gossypol | ✔ | 99%+ | |||||||||||||||||
Devimistat | ✔ | 98% | |||||||||||||||||
Disulfiram | ✔ | 98%+ | |||||||||||||||||
Enasidenib |
++++
IDH2, IC50: 12 nM |
98% | |||||||||||||||||
PluriSIn 1 | ✔ | 99%+ | |||||||||||||||||
ML390 |
+
DHODH, IC50: 0.56 μM |
99%+ | |||||||||||||||||
Teriflunomide | ✔ | 99%+ | |||||||||||||||||
Daidzin |
+++
ALDH-Ⅰ, Ki: 20 nM |
98+% | |||||||||||||||||
18β-Glycyrrhetinic acid | ✔ | 99% | |||||||||||||||||
RRx-001 | ✔ | 95% | |||||||||||||||||
NCT-503 |
+
PHGDH, IC50: 2.5 μM |
99%+ | |||||||||||||||||
Vorasidenib | ✔ | 99%+ | |||||||||||||||||
Ammonium Glycyrrhizinate(x:1) | ✔ | 98+% | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
描述 | In the lactate dehydrogenase (LDH) family, Lactate dehydrogenase A (LDHA) is the enzyme that catalyzes the conversion of L-lactate and NAD to pyruvate and NADH in the final step of anaerobic glycolysis. Another isoform, Lactate dehydrogenase B (LDHB) catalyzes the interconversion of pyruvate and lactate with concomitant interconversion of NADH and NAD+ in a post-glycolysis process. As altered glycolytic metabolism is a feature of cancer cells, inhibition of LDHA and LDHB, thus reducing glycolysis was assumed to have anti-tumor potential. R)-GNE-140 is an LDH inhibitor. Based on enzymatic assays, the inhibitory IC50 values of (R)-GNE-140 against LDHA and LDHB are 3 nM and 5 nM, respectively. Results of a lactate production assay in pancreatic MiaPaca2 cell line shows that (R)-GNE-140 inhibited lactate production with the IC50 of 0.67 μM[2]. In an experiment to determine the IC50s of (R)-GNE-140 across a panel of pancreatic cell lines, it was reported that the 4 cell lines of MiaPaca2, KP2, PSN1 and Hup-T3 are sensitive to (R)-GNE-140 with IC50s below 5 μM. When MiaPaca-2 cells were incubated with 2 μM (R)-GNE-140 for the 1 - 5 days and then assessed for levels of active caspase-3 or sub-2N content, levels of active caspase-3 increased within 1 - 2 d and peaked at around days 2 - 3, while obvious increase in cell death (appearance of cells with a DNA content <2N) was first detected at day 3[3]. In xenograft studies, (R)-GNE-140 was administrated to MiaPaca-2-tumor-bearing mice twice daily at 100, 200, and 400 mg/kg for a total of 7 days. A dose-dependent significant reduction in lactate levels and a corresponding increase in both pyruvate and glycerol-3-phosphate levels was observed within 1h of the last GNE-140 dose but not 6h after the last dose, suggesting rapid clearance of GNE-140 in vivo. Consequently, tumor-bearing mice treated for 21 d with twice daily administration of 100, 200 and 400 mg/kg GNE-140 showed no tumor growth inhibition when compared to vehicle control animals[3]. |
作用机制 | X-ray structure assay revealed that GNE-140 bound to LDHA by forming hydrogen bonds in the active site adjacent to NADH[3]. |
Dose | Mice: 5 mg/kg - 200 mg/kg[1] (p.o.); 1 mg/kg[1] (i.v.) | ||||||||||||||||||
Administration | p.o., i.v. | ||||||||||||||||||
Pharmacokinetics |
|
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.00mL 0.40mL 0.20mL |
10.02mL 2.00mL 1.00mL |
20.04mL 4.01mL 2.00mL |
CAS号 | 2003234-63-5 |
分子式 | C25H23ClN2O3S2 |
分子量 | 499.045 |
别名 | |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Keep in dark place,Sealed in dry,2-8°C |
溶解度 |
DMSO: 50 mg/mL(100.19 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |